Home › Medical › Cannabis and Testosterone
⚐ Flag an error How this page was made
Also known as: THC and testosterone · weed and T levels · cannabis and male hormones

Cannabis and Testosterone

What research shows about cannabis, testosterone levels, and male reproductive health.

Automated fact-check pass
12 cited sources
Published
Last reviewed
How this page was made

This article is for information only and is not medical advice. Talk to a doctor before using cannabis for a health condition, and do not stop or change prescribed treatment on your own.

↯ The honest take

The internet tells two opposite stories: 'weed destroys testosterone' and 'weed boosts testosterone.' Both oversimplify. The real story is messier: short-term dips are possible but small and inconsistent, and chronic users often show tolerance. The *stronger* signal is cannabis affecting sperm quality — which matters for fertility even when testosterone looks normal. For testosterone itself, cannabis is not a treatment and won't replace sleep, training, or doctor supervision if you have actual hypogonadism.

Not Medical Advice

This article is not medical advice. It summarizes published research for educational purposes. If you have symptoms of low testosterone (fatigue, low libido, mood changes, loss of muscle mass), or are concerned about fertility, see a licensed physician and get bloodwork. Do not start, stop, or change cannabis use based on this article without talking to a clinician — especially if you are on hormone therapy, trying to conceive, or being treated for any endocrine condition.

Plain-Language Summary

The cannabis-testosterone story exists in two competing versions online.

Version 1: "Weed crashes your T." Rests on a landmark 1974 study showing lower testosterone in chronic smokers [1], supported by animal research demonstrating THC's suppressive effect on the hypothalamic-pituitary-gonadal (HPG) axis — the hormonal chain that regulates testosterone production [2].

Version 2: "Weed boosts T." Built on a 2017 analysis of U.S. health survey data (NHANES) that found slightly higher serum testosterone in recent cannabis users [3].

What the evidence actually shows: Human studies are small, vary widely, and cannot account for all relevant confounders. The difference in either direction is modest. For most healthy men, occasional or regular cannabis use produces little measurable change in testosterone. However, the stronger and more consistent signal in published literature concerns sperm — count, motility, and shape — which matters for fertility independent of testosterone levels [4][5]. Strong evidence for reproducible sperm findings; Weak / limited for serum testosterone effects.

What Probably Works (Strong Evidence)

Nothing. Cannabis is not an evidence-based treatment for hypogonadism, testosterone deficiency, or male infertility. There is no controlled trial showing cannabis raises testosterone, improves fertility outcomes, or offers an alternative to established therapies. No data

If you are seeking a plant-based way to raise testosterone, the evidence-backed interventions are: resistance training, sleep optimization, weight loss if overweight, and — when clinically indicated — prescription testosterone replacement therapy (TRT) under physician supervision. Cannabis does not belong in this list.

What Might Work or Matter (Weak to Moderate Evidence)

Transient testosterone dips after acute cannabis use. Several small human studies have documented modest, short-term drops in serum testosterone (1–6 hours after smoking) in some — but not all — participants [1][6]. The magnitude is usually small, and effects are temporary. Weak / limited

Tolerance with chronic use. Some cross-sectional and controlled studies suggest regular users develop tolerance to acute hormonal effects; baseline testosterone in daily users often resembles that of non-users [3][6]. Weak / limited

Sperm effects — the most robust finding. A 2015 study of 1,215 young Danish men found cannabis users had lower sperm concentration and reduced motility compared with non-users [4]. Systematic reviews confirm an association between regular use and impaired semen parameters [5]. The endocannabinoid system participates in male germ cell development, providing a plausible biological mechanism [2]. Whether this translates to infertility in otherwise healthy men remains unclear, but the association is consistent. Strong evidence for the association; Weak / limited for clinical infertility outcomes in healthy men.

Erectile function. Mixed evidence. Some survey-based studies link heavy cannabis use to erectile dysfunction; others report no association or improvement at low doses [7]. The quality of evidence is low. Disputed

What Doesn't Work / Weak or No Evidence

"Cannabis raises testosterone" as a clinical benefit. The NHANES finding [3] is cross-sectional and cannot prove causation; the observed difference was small and inconsistent across subgroups. Do not use this as a reason to start or increase cannabis use. Weak / limited

"Indica lowers testosterone more than sativa." No evidence. The indica/sativa distinction is not a reliable predictor of pharmacological or hormonal effects [8]. No data

CBD as a testosterone booster. Marketed online with no supporting clinical trials. Preliminary animal data actually suggest CBD may inhibit testosterone synthesis at high doses through enzyme inhibition [9]. No data in humans.

Gynecomastia (breast enlargement) caused by cannabis. Sustained by a single 1972 case report [10]. Controlled studies have not confirmed cannabis as a cause of gynecomastia. Anecdote

What We Don't Know

The research base remains thin, partly because cannabis' federal Schedule I status in the U.S. historically restricted funding and regulatory approval for endocrine studies.

Comparison with Standard Treatments

If a healthcare provider diagnoses hypogonadism (confirmed by two morning testosterone measurements, plus symptoms), standard clinical care includes:

1. Lifestyle optimization (first-line). Weight loss, sleep hygiene, sleep apnea treatment, and resistance training often produce meaningful testosterone increases without medication [11]. Strong evidence

2. Testosterone replacement therapy (TRT). Injections, gels, transdermal patches, or pellets, prescribed and monitored by an endocrinologist or urologist. Effective for symptomatic hypogonadism, but carries trade-offs: suppression of natural sperm production, increased hematocrit, and the need for ongoing cardiovascular monitoring [11]. Strong evidence

3. Treating root causes. Pituitary dysfunction, medication side effects (opioids, antipsychotics), chronic disease, sleep apnea.

Cannabis is not part of evidence-based treatment and should not replace any of these approaches. If you suspect cannabis is contributing to low libido, fatigue, or fertility concerns, a trial cessation of 3–6 months (covering at least one full cycle of sperm production) with bloodwork before and after is reasonable and low-risk.

Risks and Practical Considerations

Fertility impact. If you or a partner are attempting to conceive, the strongest recommendation from evidence is to reduce or stop cannabis use for at least 3 months (one full spermatogenesis cycle) before attempting conception [4][5]. Strong evidence

Adolescent development. Endocannabinoid signaling is involved in pubertal development. Heavy adolescent cannabis use is associated with endocrine and neurodevelopmental concerns and should be avoided [12]. Weak / limited

Drug interactions. Cannabis inhibits and induces multiple CYP450 enzymes. If you take TRT, aromatase inhibitors (anastrozole), clomiphene, or human chorionic gonadotropin (hCG), inform your prescriber of cannabis use. See Cannabis and Polypharmacy Risks for details.

Symptom overlap. Fatigue, low libido, and brain fog overlap heavily among poor sleep, depression, heavy cannabis use itself, and actual low testosterone. Obtain bloodwork before attributing symptoms to a hormonal cause.

Self-medication trap. Some men use cannabis hoping to manage low-mood or low-energy symptoms. If those symptoms are actually rooted in endocrine dysfunction, cannabis will not treat the underlying cause and may worsen the problem.

Sources

  1. Peer-reviewed Kolodny RC, Masters WH, Kolodner RM, Toro G. Depression of plasma testosterone levels after chronic intensive marihuana use. New England Journal of Medicine. 1974;290(16):872–874.
  2. Peer-reviewed Murphy LL, Muñoz RM, Adrian BA, Villanúa MA. Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion. Neurobiology of Disease. 1998;5(6 Pt B):432–446.
  3. Peer-reviewed Thistle JE, Graubard BI, Braunlin M, Vesper H, Trabert B, Cook MB, McGlynn KA. Marijuana use and serum testosterone concentrations among U.S. males. Andrology. 2017;5(4):732–738.
  4. Peer-reviewed Gundersen TD, Jørgensen N, Andersson AM, et al. Association between use of marijuana and male reproductive hormones and semen quality: a study among 1,215 healthy young men. American Journal of Epidemiology. 2015;182(6):473–481.
  5. Peer-reviewed Payne KS, Mazur DJ, Hotaling JM, Pastuszak AW. Cannabis and male fertility: a systematic review. Journal of Urology. 2019;202(4):674–681.
  6. Peer-reviewed Cone EJ, Johnson RE, Moore JD, Roache JD. Acute effects of smoking marijuana on hormones, subjective effects and performance in male human subjects. Pharmacology Biochemistry and Behavior. 1986;24(6):1749–1754.
  7. Peer-reviewed Pizzol D, Demurtas J, Stubbs B, et al. Relationship between cannabis use and erectile dysfunction: a systematic review and meta-analysis. American Journal of Men's Health. 2019;13:1557988319892464.
  8. Peer-reviewed Piomelli D, Russo EB. The Cannabis sativa versus Cannabis indica debate: an interview with Ethan Russo, MD. Cannabis and Cannabinoid Research. 2016;1(1):44–46.
  9. Peer-reviewed Watanabe K, Motoya E, Matsuzawa N, et al. Marijuana extracts possess the effects like the endocrine disrupting activity on adrenal steroidogenic enzyme genes. Toxicology. 2005;206(3):471–478.
  10. Peer-reviewed Harmon J, Aliapoulios MA. Gynecomastia in marihuana users. New England Journal of Medicine. 1972;287(18):936.
  11. Peer-reviewed Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2018;103(5):1715–1744.
  12. Government National Academies of Sciences, Engineering, and Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research. Washington, DC: The National Academies Press; 2017.

How this page was made

Generation history

Oct 30, 2026
Revision
Oct 30, 2026
Fact-check pass — raised 10 flags
May 11, 2026
Fact-check pass — raised 2 flags
May 11, 2026
Initial draft

Drafted with AI assistance and checked by a separate automated fact-check pass. Not every article has been read by a person. See how articles are made.